Cg Oncology (CGON) Q2 Loss Widens 93%
CG Oncology, Inc. Common stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $62.29
+2.3% in 1d after detection
Post-detection moves
1h
—
1d
+2.3%
3d
+1.5%
7d
-1.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS